SCHEER - Request for an update of the guidelines on the benefit-risk assessment of the presence of
phthalates in certain medical devices covering phthalates, which are carcinogenic,
mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties

Agenda - 3rd Live Webinar of the Thematic Network DisQo: Antidiscrimination & health equity - Time for action! (30 March 2023, 11.00-12.30 CET)

Presentations and recording - 2nd Live Webinar of the Thematic Network DisQo: anti-discrimination & health equity - The importance of equality data (23 March 2023)

Agenda - Open virtual meeting of the "Supporting Ukraine, neighbouring EU Member States and Moldova" - EU Health Policy Platform Network (3 April 2023, 15.30-17.00 CET)

SCHEER - Minutes of the WG on Draft Environmental Quality Standards for the Water Framework Directive Priority Substances & groundwater quality standards of 16 March 2023

Agenda - 2nd Live Webinar of the Thematic Network: Navigating Health Inequalities in the EU through Artificial Intelligence (27 March, 16.00 - 17.00 CET, Brussels time)

SCCS - Final Opinion on Hydroxyapatite (nano)

SCCS - Final Opinion on Sodium bromothymol blue (C186) (CAS No. 34722-90-2, EC No. 252-169-7)

Agenda - PHEG sub-group on vaccination (30 March 2023)